Trial
NCT07049081
A Study of LUCAR-G79 in Subjects With Relapsed/Refractory Autoimmune Diseases
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Nanjing Legend Biotech Co.
Collaborators
—
Condition
Relapsed/Refractory Autoimmune Diseases
Intervention
LUCAR-G79 T cells
Why stopped
pipeline adjustment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-16